Jul 2026· Ageing Research Reviews· Vol 121, pp.
103247
· 0 citations· 209 references
Medicine
TL;DR
This review provides a comprehensive overview of current AI applications in vascular aging, spanning from basic mechanistic research to clinical risk prediction and discusses future directions and key challenges, including the need for external validation, algorithmic fairness, domain adaptation, and model interpretability.
Abstract
Vascular aging is a fundamental contributor to the development of chronic diseases and has emerged as a critical focus in biomedical research. With the rapid advancement of artificial intelligence (AI), new opportunities have arisen to enhance the precision and efficiency of vascular aging studies. AI techniques, particularly those applied to large-scale multi-omics and medical imaging data, enable the identification of novel biomarkers and the development of robust models to quantify the rate and extent of vascular aging. For example, AI has been successfully deployed for multi-omics biomarker discovery, automated quantification of coronary plaque and calcium scoring from CT imaging, and the development of vascular aging clocks based on retinal images or photoplethysmography (PPG). These approaches facilitate early detection, individualized risk assessment, and potential intervention strategies. This review provides a comprehensive overview of current AI applications in vascular aging, spanning from basic mechanistic research to clinical risk prediction. It also discusses future directions and key challenges, including the need for external validation, algorithmic fairness, domain adaptation, and model interpretability, emphasizing the transformative role of AI in advancing precision medicine for vascular health.
Coronary artery disease (CAD) is a typical age-related chronic condition, with its development and progression spanning a long course of life and exhibiting significant inter-individual heterogeneity. Traditional risk assessment models based on chronological age and single risk factors are often insufficient to capture...
Ru Sun, Wei-Jian Hang, Ling Zhou et al.· International Journal of Dru...· 0 citations
Recent advances in the application of Machine Learning (ML) techniques to transcriptome datasets of CVD patients are sampled in the hopes of progressing the understanding of underlying pathophysiology, improving the ability to detect disease, and refining the methods of risk stratification of patients.
This review presents a detailed discussion of the state of the art, focusing on the strengths and limitations of the individual technologies and an outline of the promising, most recent results of both clinical and preclinical research in this field related to stroke.
Emilia Conti, M. Baldereschi, A. Di Carlo et al.· Journal of Clinical Medicine· 0 citations
This review focuses on the transition from single-omics to integrative multi-omics analysis, which helps overcome the constraints of individual omics strategies and provides a more systematic understanding of PD pathogenesis.
This paper summarizes recent advances in biosensor technologies, AI-derived biomarkers, and predictive frameworks used to help identify patients more accurately, monitor their progress continuously, and receive optimized therapies.
Novel markers for diagnosing diabetic cardiomyopathy have the potential to improve the prognosis of DCM patients and enhance the identification and management of this condition, and artificial intelligence-based multimodal approaches may provide new opportunities for cardiovascular risk stratification and DCM screening...
Sheng-Ying Jia, Li Wang, Zuowei Pei· Journal of Cardiovascular De...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.